Status:
COMPLETED
Insulin Resistance in Idiopathic Oligospermia and Azoospermia
Lead Sponsor:
The Egyptian IVF-ET Center
Conditions:
Insulin Resistance
Oligospermia
Eligibility:
MALE
25-55 years
Phase:
NA
Brief Summary
Insulin resistance in men can be the underlying major factor in reproductive abnormalities ( chronic hypospermatogenesis ) as well as metabolic abnormalities similar to polycystic ovarian syndrome ( P...
Detailed Description
During the past decade IR has been recognized as a major contributor to the pathogenesis of chronic anovulation, hyperandrogenism and metabolic abnormalities associated with PCOS . Theoretically IR in...
Eligibility Criteria
Inclusion
- sperm count less than 10 million per milliliter
- non-obstructive azoospermia
Exclusion
- high FSH ( \> 10 mIU/ ml )
- high prolactin ( \> 36 mIU/ml )
- abnormal karyotype
- AZF
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01509482
Start Date
January 1 2012
End Date
April 1 2014
Last Update
November 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Egyptian IVF-ET center
Cairo, Egypt, Egypt, 11431